{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:08:42Z","timestamp":1764936522229},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T00:00:00Z","timestamp":1256601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12012-009-9054-2","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T05:38:00Z","timestamp":1256535480000},"page":"201-210","source":"Crossref","is-referenced-by-count":18,"title":["Erythropoietin Promotes Deleterious Cardiovascular Effects and Mortality Risk in a Rat Model of Chronic Sports Doping"],"prefix":"10.1007","volume":"9","author":[{"given":"Nuno","family":"Piloto","sequence":"first","affiliation":[]},{"given":"Helena M.","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Edite","family":"Teixeira-Lemos","sequence":"additional","affiliation":[]},{"given":"Belmiro","family":"Parada","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Garrido","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Sereno","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Lina","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"El\u00edsio","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Belo","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[]},{"given":"Frederico","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,10,27]]},"reference":[{"key":"9054_CR1","first-page":"724","volume":"83","author":"C Lacombe","year":"2006","unstructured":"Lacombe, C., & Mayeux, P. (2006). Biology of erythropoietin. Haematologica, 83, 724\u2013732.","journal-title":"Haematologica"},{"key":"9054_CR2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00467-006-0284-2","volume":"21","author":"D Fliser","year":"2006","unstructured":"Fliser, D., Bahlmann, F. H., & Haller, H. (2006). EPO: Renoprotetion beyond anemia correction. Pediatric Nephrology, 21, 1785\u20131789.","journal-title":"Pediatric Nephrology"},{"key":"9054_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bjp.2008.89","volume":"154","author":"S Elliott","year":"2008","unstructured":"Elliott, S. (2008). Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. British Journal of Pharmacology, 154, 529\u2013541.","journal-title":"British Journal of Pharmacology"},{"key":"9054_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35015164","volume":"405","author":"F Lasne","year":"2000","unstructured":"Lasne, F., & de Ceaurriz, J. (2000). Recombinant human erythropoietin in urine. Nature, 405, 635.","journal-title":"Nature"},{"key":"9054_CR5","first-page":"75","volume":"13","author":"N Robinson","year":"2003","unstructured":"Robinson, N., Mangin, P., & Saugy, M. (2003). Erythropoietin abuse in sports. Sysmex Journal International, 13, 75\u201377.","journal-title":"Sysmex Journal International"},{"key":"9054_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S1517-86922003000300006","volume":"9","author":"R Bento","year":"2003","unstructured":"Bento, R., Damasceno, L., & Neto, F. (2003). Eritropoietina recombinante humana no esporte: uma revis\u00e3o. Revista Brasileira de Medicina do Esporte, 9, 169\u2013180.","journal-title":"Revista Brasileira de Medicina do Esporte"},{"key":"9054_CR7","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V95.9.2983.009k27_2983_2989","volume":"95","author":"PJ Stohlawetz","year":"2000","unstructured":"Stohlawetz, P. J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H. G., et al. (2000). Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood, 95, 2983\u20132999.","journal-title":"Blood"},{"key":"9054_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/380113a0","volume":"380","author":"R Gareau","year":"1996","unstructured":"Gareau, R., Audran, M., Baynes, R. D., Flowers, C. H., Duvallet, A., Sen\u00e9cal, L., et al. (1996). Erythropoietin abuse in athletes. Nature, 380, 113.","journal-title":"Nature"},{"key":"9054_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ptj\/75.5.426","volume":"75","author":"LA Thein","year":"1995","unstructured":"Thein, L. A., Thein, J. M., & Landry, G. L. (1995). Ergogenic aids. Physical Therapy, 75, 426\u2013439.","journal-title":"Physical Therapy"},{"key":"9054_CR10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJM199103073241014","volume":"324","author":"JW Adamson","year":"1991","unstructured":"Adamson, J. W., & Vapnek, D. (1991). Recombinant human erythropoietin to improve athletic performance. The New England Journal of Medicine, 324, 698\u2013699.","journal-title":"The New England Journal of Medicine"},{"key":"9054_CR11","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.lfs.2005.01.032","volume":"77","author":"F Reis","year":"2005","unstructured":"Reis, F., Rocha, L., Ponte, L., Alcobia, T., Almeida, L., Costa-Almeida, C., et al. (2005). Effect of preventive and regressive isosorbide 5-mononitrate treatment on catecholamine levels in plasma, platelets, adrenals, left ventricle and aorta in cyclosporin A-induced hypertensive rats. Life Science, 77, 2514\u20132528.","journal-title":"Life Science"},{"key":"9054_CR12","first-page":"1","volume":"67","author":"V Estepa","year":"2001","unstructured":"Estepa, V., R\u00f3denas, S., & Mart\u00edn, M. C. (2001). Optimizaci\u00f3n de un m\u00e9todo para la determinaci\u00f3n de la peroxidaci\u00f3n lip\u00eddica en suero humano. Anales de la Real Academia de Farmacia, 67, 1\u201317.","journal-title":"Anales de la Real Academia de Farmacia"},{"key":"9054_CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IFF Benzie","year":"1996","unstructured":"Benzie, I. F. F., & Strain, J. J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of \u2018\u2018antioxidant power\u2019\u2019: The FRAP assay. Analytical Biochemistry, 239, 70\u201376.","journal-title":"Analytical Biochemistry"},{"key":"9054_CR14","first-page":"553","volume":"33","author":"A Cruz","year":"2006","unstructured":"Cruz, A. (2006). Resist\u00eancia aer\u00f3bia e eritropoietina. Goi\u00e2nia, 33, 553\u2013572.","journal-title":"Goi\u00e2nia"},{"key":"9054_CR15","first-page":"561","volume":"85","author":"M Cazzola","year":"2002","unstructured":"Cazzola, M. (2002). A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica, 85, 561\u2013563.","journal-title":"Haematologica"},{"key":"9054_CR16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1249\/00005768-198820020-00017","volume":"20","author":"B Berglund","year":"1988","unstructured":"Berglund, B., Birgegard, G., & Hemmingsson, P. (1988). Serum erythropoietin in cross country skiers. Medicine and Science in Sports and Exercise, 20, 208\u2013209.","journal-title":"Medicine and Science in Sports and Exercise"},{"key":"9054_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00868079","volume":"63","author":"HJ Schwandt","year":"1991","unstructured":"Schwandt, H. J., Heyduck, B., Gunga, H. C., & R\u00f6cker, L. (1991). Influence of prolonged physical exercise on the erythropoietin concentration in blood. European Journal of Applied Physiology and Occupational Physiology, 63, 463\u2013466.","journal-title":"European Journal of Applied Physiology and Occupational Physiology"},{"key":"9054_CR18","first-page":"8","volume":"50293","author":"J Gauthier","year":"2001","unstructured":"Gauthier, J. (2001). Effets cardiovasculaires du dopage. Annales de Cardiologie et d\u2019Angeiologie, 50293, 8.","journal-title":"Annales de Cardiologie et d\u2019Angeiologie"},{"key":"9054_CR19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000188491","volume":"69","author":"A Torralbo","year":"1995","unstructured":"Torralbo, A., Herrerro, J. A., Portol\u00e9s, J., Fontanellas, A., & Barrientos, A. (1995). Activation of the sympathetic nervous system in hemodialyzed patients treated with erythropoietin. Nephron, 69, 350.","journal-title":"Nephron"},{"key":"9054_CR20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","volume":"293","author":"K Maiese","year":"2005","unstructured":"Maiese, K., Li, F., & Chong, Z. Z. (2005). New avenues of exploration for erythropoietin. JAMA, 293, 90\u201395.","journal-title":"JAMA"},{"key":"9054_CR21","first-page":"258","volume":"29","author":"NP Riksen","year":"2008","unstructured":"Riksen, N. P., Hausenloy, D. J., & Yellon, D. M. (2008). Erythropoietin: Ready for prime-time cardioprotection. TiPS, 29, 258\u2013267.","journal-title":"TiPS"},{"key":"9054_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10741-008-9084-z","volume":"13","author":"R Latini","year":"2008","unstructured":"Latini, R., Brines, M., & Fiordaliso, F. (2008). Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure? Heart Failure Reviews, 13, 415\u2013423.","journal-title":"Heart Failure Reviews"},{"key":"9054_CR23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","volume":"112","author":"CJ Parsa","year":"2003","unstructured":"Parsa, C. J., Matsumoto, A., Kim, J., Riel, R. U., Pascal, L. S., Walton, G. B., et al. (2003). A novel protective effect of erythropoietin in the infracted heart. The Journal of Clinical Investigation, 112, 999\u20131007.","journal-title":"The Journal of Clinical Investigation"},{"key":"9054_CR24","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2006.08.031","volume":"48","author":"E Lipsic","year":"2006","unstructured":"Lipsic, E., Schoemaker, R. G., van der Meer, P., Voors, A. A., van Veldhuisen, D. J., & van Gilst, W. H. (2006). Protective effects of erythropoietin in cardiac ischemia. Journal of the American College of Cardiology, 48, 2161\u20132167.","journal-title":"Journal of the American College of Cardiology"},{"key":"9054_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.braindev.2008.06.011","volume":"31","author":"W Tao","year":"2009","unstructured":"Tao, W., Wen, F., Zhang, H., & Liu, G. (2009). The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK\/STAT pathway in the children with cerebral plasy. Brain and Development, 31, 200\u2013207.","journal-title":"Brain and Development"},{"key":"9054_CR26","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5002482","volume":"72","author":"P Katavenin","year":"2007","unstructured":"Katavenin, P., Tungsanga, K., Eiam-Ong, S., & Nagaku, M. (2007). Antioxidative effects of erythropoietin. Kidney International, 72, S10\u2013S15.","journal-title":"Kidney International"},{"key":"9054_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/156720208784310231","volume":"5","author":"K Maiese","year":"2008","unstructured":"Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. C. (2008). Erythropoietin and oxidative stress. Current Neurovascular Research, 5, 125\u2013142.","journal-title":"Current Neurovascular Research"},{"key":"9054_CR28","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1038\/sj.cdd.4401450","volume":"11","author":"P Ghezzi","year":"2004","unstructured":"Ghezzi, P., & Brines, M. (2004). Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death and Differentiation, 11, S37\u2013S44.","journal-title":"Cell Death and Differentiation"},{"key":"9054_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/156800605774370326","volume":"5","author":"AS Manolis","year":"2005","unstructured":"Manolis, A. S., Tzeism, S., Triantafyllou, K., Michaelidis, J., Pyrros, I., Sakellaris, N., et al. (2005). Erythropoietin in heart failure and other cardiovascular diseases: Hematopoietic and pleiotropic effects. Current Drug Targets\u2014Cardiovascular and Haematological Disorders, 5, 355\u2013375.","journal-title":"Current Drug Targets\u2014Cardiovascular and Haematological Disorders"},{"key":"9054_CR30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","volume":"17","author":"DL Regidor","year":"2006","unstructured":"Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., et al. (2006). Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. Journal of the American Society of Nephrology, 17, 1181\u20131191.","journal-title":"Journal of the American Society of Nephrology"},{"key":"9054_CR31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood.V97.2.536","volume":"97","author":"KF Wagner","year":"2001","unstructured":"Wagner, K. F., Katschinski, D. M., Hasegawa, J., Schumacher, D., Meller, B., Gembruch, U., et al. (2001). Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood, 97, 536\u2013542.","journal-title":"Blood"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-009-9054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-009-9054-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-009-9054-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T07:19:33Z","timestamp":1590218373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-009-9054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,27]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9054"],"URL":"https:\/\/doi.org\/10.1007\/s12012-009-9054-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,27]]}}}